Table 5 Bioelectrical impedance analysis results for non-COVID-19 outpatients with thyroid diseases

Non-COVID-19 outpatients with thyroid diseases (n. 96)

 Subclinical hyperthyroidism (n. 19)

561.5 ± 96.0

44.7 ± 9.8

52.2 ± 6.7

53.8 ± 7.7

46.2 ± 7.7

1.3 ± 0.3

4.7 ± 1.1

 Euthyroidism (n. 57)

540.3 ± 78.3

49.0 ± 17.1

51.2 ± 6.7

50.9 ± 6.1

49.1 ± 6.1

1.1 ± 0.2

5.1 ± 1.2

 Subclinical hypothyroidism (n. 12)

552.3 ± 104.6

49.6 ± 16.0

55.0 ± 7.0

50.9 ± 4.7

49.1 ± 4.7

1.2 ± 0.3

5.1 ± 0.8

 Overt hypothyroidism (n. 7)

522.6 ± 87.8

47.7 ± 10.4

52.2 ± 8.3

49.9 ± 7.0

50.7 ± 7.0

1.2 ± 0.3

5.3 ± 1.3

 Myxedema (n. 1)

459

29

57.2

60.2

39.8

1.57

3.6